Get started
Author

Ritesh Gupta

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
2020 · Awadhesh Kumar Singh, Ritesh Gupta, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 976
PDF
Clinical considerations for patients with diabetes in times of COVID-19 epidemic
2020 · Ritesh Gupta, Amerta Ghosh, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 537
PDF
Usefulness of an Elevated Neutrophil to Lymphocyte Ratio in Predicting Long-Term Mortality After Percutaneous Coronary Intervention
2006 · Brendan K. Duffy, Hitinder S. Gurm, et al. · The American Journal of Cardiology · 422
Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India
2020 · Amerta Ghosh, Bhavya Arora, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 296
PDF
Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
2020 · Awadhesh Kumar Singh, Ritesh Gupta, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 251
PDF
Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
2020 · Amerta Ghosh, Ritesh Gupta, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 244
PDF
Diabetes and COVID-19: evidence, current status and unanswered research questions
2020 · Ritesh Gupta, Akhtar Hussain, et al. · European Journal of Clinical Nutrition · 185
PDF
Renal failure after percutaneous coronary intervention is associated with high mortality
2005 · Ritesh Gupta, Hitinder S. Gurm, et al. · Catheterization and Cardiovascular Interventions · 157
Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)
2020 · Ritesh Gupta, Anoop Misra · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 133
PDF
Smokeless Tobacco and Cardiovascular Risk
2004 · Ritesh Gupta, Hitinder Gurm, et al. · Archives of Internal Medicine · 92
Chronic Obstructive Pulmonary Disease as a Predictor of Mortality in Patients Undergoing Percutaneous Coronary Intervention
2005 · Carrie L. Selvaraj, Hitinder S. Gurm, et al. · The American Journal of Cardiology · 72
Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study
2020 · Amerta Ghosh, Ranjit Mohan Anjana, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 70
PDF
Preprocedural white blood cell count and death after percutaneous coronary intervention
2003 · Hitinder S Gurm, Deepak L Bhatt, et al. · American Heart Journal · 63
Outcomes at One-Year Follow-up of Women and Men With Coronary Artery Disease Discharged From Cardiac Rehabilitation: WHAT BENEFITS ARE MAINTAINED?
2007 · Ritesh Gupta, Bonnie K. Sanderson, et al. · Journal of Cardiopulmonary Rehabilitation and Prevention · 57
Epidemiology of microvascular complications of diabetes in South Asians and comparison with other ethnicities
2016 · Ritesh Gupta, Anoop Misra · Journal of Diabetes · 56
Type 2 diabetes in South Asians
2025 · Anoop Misra, Naveed Sattar, et al. · BMJ · 45
Patterns of β-blocker utilization in patients with chronic heart failure: experience from a specialized outpatient heart failure clinic
2003 · Ritesh Gupta, W.H.Wilson Tang, et al. · American Heart Journal · 44
Dapagliflozin Improves Body Fat Patterning, and Hepatic and Pancreatic Fat in Patients With Type 2 Diabetes in North India
2022 · Amerta Ghosh, Koel Dutta, et al. · The Journal of Clinical Endocrinology & Metabolism · 39
PDF
Race/ethnicity and challenges for optimal insulin therapy
2021 · Nayla Cristina do Vale Moreira, Antonio Ceriello, et al. · Diabetes Research and Clinical Practice · 39
PDF
COVID19 in South Asians/Asian Indians: Heterogeneity of data and implications for pathophysiology and research
2020 · Ritesh Gupta, Anoop Misra · Diabetes Research and Clinical Practice · 38
PDF
Heterogeneity in presentation of hyperglycaemia during COVID-19 pandemic: A proposed classification
2021 · Anoop Misra, Amerta Ghosh, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 31
PDF
Why do patients fail to receive β-blockers for chronic heart failure over time? A “real-world” single-center, 2-year follow-up experience of β-blocker therapy in patients with chronic heart failure
2005 · Anoop C. Parameswaran, W.H. Wilson Tang, et al. · American Heart Journal · 30
Comparing the efficacy and safety profile of sitagliptin versus glimepiride in patients of type 2 diabetes mellitus inadequately controlled with metformin alone.
2012 · Swati Srivastava, G N Saxena, et al. · PubMed · 29
COVID-19 associated mucormycosis: A Descriptive Multisite Study from India
2021 · Ritesh Gupta, Jothydev Kesavadev, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 26
PDF
Marked erythrocytosis during treatment with sodium glucose cotransporter-2 inhibitors-report of two cases
2020 · Ritesh Gupta, Aanchal Gupta, et al. · Diabetes Research and Clinical Practice · 23
Works count: 53
Citation count: 4,108
H-index: 24
I10-index: 32
Year
Topic
Type